Structure-guided design of partial agonists at an opioid receptor

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Chronic pain and opioid overdose deaths necessitate non-addictive analgesics with novel mechanisms.
• The delta opioid receptor (δOR) is a promising target due to its lack of respiratory depression compared to the mu opioid receptor (µOR).
• Previous δOR full agonists caused seizures, limiting clinical utility; partial agonists offer controlled activation but their mechanisms are unclear.

Purpose of the Study:

• To develop and characterize a selective δOR partial agonist with improved safety and efficacy.
• To elucidate the molecular mechanism underlying partial agonism at the δOR.

Main Methods:

• Structure-based design of a bitopic ligand (C6-Quino).
• Functional assays to assess G-protein and arrestin pathway activity.
• Cryo-electron microscopy (cryo-EM) to determine receptor-ligand interactions.
• In vivo studies in chronic pain models.

Main Results:

• C6-Quino selectively acts as a δOR partial agonist.
• Differential G-protein and arrestin pathway signaling was observed.
• Cryo-EM confirmed interaction with the sodium binding pocket.
• C6-Quino demonstrated oral analgesic activity in chronic pain models without causing seizures or µOR-related adverse effects.

Conclusions:

• C6-Quino represents a new strategy for developing δOR-targeted analgesics.
• This partial agonist offers pain relief without the adverse effects of full agonists or traditional opioids.
• Provides a framework for optimizing signaling profiles of Class A GPCRs.